Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 144 clinical trials for: 150 miles

Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  • Recruiting
NCT04649242
Sex: All
Age: 6 - 17
Locations: 50
View study
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
  • Recruiting
NCT06866405
Sex: All
Age: 0+
Locations: 50
View study
Recruiting
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
  • Recruiting
NCT05995964
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
  • Recruiting
NCT07062965
Sex: All
Age: 18+
Locations: 344
View study
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
  • Recruiting
NCT06679140
Sex: All
Age: 12+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
  • Recruiting
NCT05020236
Sex: All
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  • Recruiting
NCT06641466
Sex: Female
Age: 18 - 45
Locations: 122
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
  • Recruiting
NCT05355701
Sex: All
Age: 16+
Locations: 18
View study
Recruiting
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
  • Recruiting
NCT05070845
Sex: All
Age: 18 - 70
Locations: 16
View study
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
  • Recruiting
NCT05623020
Sex: All
Age: 18+
Locations: 39
View study
...